While people are still dealing with the Covid-19 pandemic, the effects of monkeypox are being seen around the world. However, according to a new study, the dearth in high quality and updated clinical guidance on the latter disease may actually be hampering effective and safe treatment of the infection. 

Existing guidance, such as it is, too often lacks sufficient detail, fails to include different groups, and is contradictory, said the researchers from universities of Oxford in the UK, Bristol in Australia, and Liverpool School of Tropical Medicine, among others.

They said that "the lack of clarity between guidelines creates uncertainty for clinicians treating patients with [monkeypox] which may impact patient care."